Serological responses to experimental Norwalk virus infection measured using a quantitative duplex time-resolved

Owen Kavanagh1, Mary K Estes, Amanda Reeck

  • 1Department of Molecular Virology and Microbiology, Baylor College of Medicine, One Baylor Plaza, Houston, Texas 77030, USA.

Insights

A new assay simultaneously detects Norwalk virus (NV)-specific IgA and IgG antibodies. This dissociation-enhanced lanthanide fluorescent immunoassay (DELFIA) detects seroconversion earlier than traditional ELISA methods.

Area of Science:

  • Immunology
  • Virology
  • Biochemistry

Background:

  • Norwalk virus (NV) is a common cause of gastroenteritis.
  • Accurate and timely detection of NV infection is crucial for public health surveillance.
  • Current diagnostic methods may have limitations in early detection of seroconversion.

Purpose of the Study:

  • To develop a novel quantitative assay for simultaneous detection of NV-specific IgA and IgG antibodies.
  • To evaluate the performance of the new assay compared to a reference method.

Main Methods:

  • Development of a quantitative duplex time-resolved fluorescence assay using dissociation-enhanced lanthanide fluorescent immunoassay (DELFIA) technology.
  • Simultaneous measurement of NV-specific IgA and IgG antibodies.
  • Comparison with a reference total immunoglobulin enzyme-linked immunosorbent assay (ELISA) for detecting seroconversion in experimentally infected individuals.

Main Results:

  • The developed duplex DELFIA assay successfully measured NV-specific IgA and IgG antibodies simultaneously.
  • The assay demonstrated superior performance by detecting seroconversion at an earlier time point compared to the reference ELISA.
  • This indicates enhanced sensitivity and speed in diagnosing NV infection.

Conclusions:

  • The duplex DELFIA assay is a sensitive and efficient tool for diagnosing Norwalk virus infections.
  • This assay allows for earlier detection of seroconversion, improving diagnostic capabilities.
  • The method holds promise for improved NV surveillance and clinical management.

Related Concept Videos